Multiple sclerosis following SARS-CoV-2 infection.

Autor: Palao M; Neurology Department, Complejo Hospitalario Universitario de Albacete, Castilla- La Mancha, Spain. Electronic address: mariapalaorico@gmail.com., Fernández-Díaz E; Neurology Department, Complejo Hospitalario Universitario de Albacete, Castilla- La Mancha, Spain., Gracia-Gil J; Neurology Department, Complejo Hospitalario Universitario de Albacete, Castilla- La Mancha, Spain., Romero-Sánchez CM; Neurology Department, Complejo Hospitalario Universitario de Albacete, Castilla- La Mancha, Spain., Díaz-Maroto I; Neurology Department, Complejo Hospitalario Universitario de Albacete, Castilla- La Mancha, Spain., Segura T; Neurology Department, Complejo Hospitalario Universitario de Albacete, Castilla- La Mancha, Spain.
Jazyk: angličtina
Zdroj: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Oct; Vol. 45, pp. 102377. Date of Electronic Publication: 2020 Jul 07.
DOI: 10.1016/j.msard.2020.102377
Abstrakt: SARS-CoV-2 infection can produce neurological features. The most common are headache, anosmia and dysgeusia but patients may also develop other central nervous system (CNS) injuries. We present a patient affected by Covid-19 who initially consulted for decreased visual acuity. The MRI showed inflammation in the right optic nerve and demyelinating lesions in the CNS. We speculate that an immune mechanism induced by SARS-CoV-2, which can activate lymphocytes and an inflammatory response, plays a role in the clinical onset of the disease. This pathogen may be associated with either the triggering or the exacerbation of inflammatory/demyelinating disease.
Competing Interests: Declaration of Competing Interest The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this articles.
(Copyright © 2020 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: